<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38947233</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Long COVID management: a mini review of current recommendations and underutilized modalities.</ArticleTitle><Pagination><StartPage>1430444</StartPage><MedlinePgn>1430444</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1430444</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1430444</ELocationID><Abstract><AbstractText>Long COVID is a condition that develops in a subset of patients after COVID-19 infection comprising of symptoms of varying severity encompassing multiple organ systems. Currently, long COVID is without consensus on a formal definition, identifiable biomarkers, and validated treatment. Long COVID is expected to be a long-term chronic condition for a subset of patients and is associated with suffering and incapacity. There is an urgent need for clear management guidelines for the primary care provider, who is essential in bridging the gap with more specialized care to improve quality of life and functionality in their patients living with long COVID. The purpose of this mini review is to provide primary care providers with the latest highlights from existing literature regarding the most common long COVID symptoms and current management recommendations. This review also highlights the underutilized interventions of stellate ganglion blocks and low-dose naltrexone, both with well-established safety profiles demonstrated to improve quality of life and functionality for patients suffering with some symptoms of long COVID, and encourages prompt referral to interventional pain management.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Dietz and Brondstater.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dietz</LastName><ForeName>Tiffany K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>School of Health Professions, Shenandoah University, Winchester, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brondstater</LastName><ForeName>Kirsten N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>School of Health Professions, Shenandoah University, Winchester, VA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">low-dose naltrexone</Keyword><Keyword MajorTopicYN="N">management</Keyword><Keyword MajorTopicYN="N">post COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">stellate ganglion block</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>1</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38947233</ArticleId><ArticleId IdType="pmc">PMC11211541</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1430444</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak &#x2013; an update on the status. Mil Med Res. (2020) 7:11. doi: 10.1186/s40779-020-00240-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-020-00240-0</ArticleId><ArticleId IdType="pmc">PMC7068984</ArticleId><ArticleId IdType="pubmed">32169119</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Yang M, Lai CL. Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. (2021) 9:966. doi: 10.3390/biomedicines9080966, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Qin C. Expression pattern and function of SARS-CoV-2 receptor ACE2. Biosaf Health. (2021) 3:312&#x2013;8. doi: 10.1016/j.bsheal.2021.08.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bsheal.2021.08.003</ArticleId><ArticleId IdType="pmc">PMC8393493</ArticleId><ArticleId IdType="pubmed">34466800</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al. . Systematic review of the prevalence of long COVID. Open forum. Infect Dis. (2023) 10:ofad233. doi: 10.1093/ofid/ofad233, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B, Wills M, Sithole N. Long COVID: what is known and what gaps need to be addressed. Br Med Bull. (2023) 147:6&#x2013;19. doi: 10.1093/bmb/ldad016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldad016</ArticleId><ArticleId IdType="pmc">PMC10502447</ArticleId><ArticleId IdType="pubmed">37434326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum. (2022) 3:e221809. doi: 10.1001/jamahealthforum.2022.1809</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Achleitner M, Steenblock C, D&#xe4;nhardt J, Jarzebska N, Kardashi R, Kanczkowski W, et al. . Clinical improvement of long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol Psychiatry. (2023) 28:2872&#x2013;7. doi: 10.1038/s41380-023-02084-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02084-1</ArticleId><ArticleId IdType="pmc">PMC10152027</ArticleId><ArticleId IdType="pubmed">37131073</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy MW. Paxlovid as a potential treatment for long COVID. Expert Opin Pharmacother. (2023) 24:1839&#x2013;43. doi: 10.1080/14656566.2023.2262387, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2023.2262387</ArticleId><ArticleId IdType="pubmed">37731377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee YJ, Fan BE, Young BE, Dalan R, Lye DC. Clinical trials on the pharmacological treatment of long COVID: a systematic review. J Med Virol. (2023) 95:e28289. doi: 10.1002/jmv.28289, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28289</ArticleId><ArticleId IdType="pmc">PMC9878018</ArticleId><ArticleId IdType="pubmed">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvucci F, Codella R, Coppola A, Zacchei I, Grassi G, Anti ML, et al. . Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation. Front Cardiovasc Med. (2023) 10:1202696. doi: 10.3389/fcvm.2023.1202696, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1202696</ArticleId><ArticleId IdType="pmc">PMC10388239</ArticleId><ArticleId IdType="pubmed">37529714</ArticleId></ArticleIdList></Reference><Reference><Citation>Samarelli F, Graziano G, Gambacorta N, Graps E, Leonetti F, Nicolotti O, et al. . Small molecules for the treatment of long-COVID-related vascular damage and abnormal blood clotting: a patent-based appraisal. Viruses. (2024) 16:450. doi: 10.3390/v16030450, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16030450</ArticleId><ArticleId IdType="pmc">PMC10976273</ArticleId><ArticleId IdType="pubmed">38543815</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Pretorius E. The potential role of ischaemia&#x2013;reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J. (2022) 479:1653&#x2013;708. doi: 10.1042/BCJ20220154, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . COVID-19 cases. WHO COVID-19 Dashboard. (2024). Available at: https://data.who.int/dashboards/covid19/cases (Accessed Apr 13, 2024).</Citation></Reference><Reference><Citation>Iqbal P, Ata F, Chaudhry H, Muthanna B, Waqas Younas H, Munamm SA, et al. . Post-COVID-19-associated multiorgan complications or &#x201c;long COVID&#x201d; with literature review and management strategy discussion: a meta-analysis. Health Sci Rep. (2023) 6:e1211. doi: 10.1002/hsr2.1211, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1211</ArticleId><ArticleId IdType="pmc">PMC10103688</ArticleId><ArticleId IdType="pubmed">37064319</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. . Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. (2021) 92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. . Symptoms, complications and management of long COVID: a review. J R Soc Med. (2021) 114:428&#x2013;42. doi: 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M, Alcaide P, Asselbergs FW, Brundel BJJM, Camici GG, Martins PDC, et al. . Long COVID and the cardiovascular system&#x2014;elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint scientific statement of the ESC working groups on cellular biology of the heart and myocardial and pericardial diseases. Cardiovasc Res. (2023) 119:336&#x2013;56. doi: 10.1093/cvr/cvac115, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ND, Slaughter D, Edwards D, Dalton A, Perrine C, Vahratian A, et al. . Long COVID and significant activity limitation among adults, by age &#x2014; United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb Mortal Wkly Rep. (2023) 72:866&#x2013;70. doi: 10.15585/mmwr.mm7232a3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Median age of the labor force, by sex, race, and ethnicity: U.S. Bureau of Labor Statistics . Available at: https://www.bls.gov/emp/tables/median-age-labor-force.htm (Accessed Mar 30, 2024).</Citation></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens De Noordhout C, et al. . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. (2022) 54:1473&#x2013;87. doi: 10.1080/07853890.2022.2076901, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB, Mechanistic Pathway Task RECOVER, et al. . Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). eLife. (2023) 12:e86002. doi: 10.7554/eLife.86002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Peluso MJ, Rodgers K, Aberg JA, Patterson TF, Tamburro R, et al. . Therapeutic trials for long COVID-19: a call to action from the interventions taskforce of the RECOVER initiative. Front Immunol. (2023) 14:1129459. doi: 10.3389/fimmu.2023.1129459, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1129459</ArticleId><ArticleId IdType="pmc">PMC10034329</ArticleId><ArticleId IdType="pubmed">36969241</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. (2021) 18:2621. doi: 10.3390/ijerph18052621, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. (2022) 23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>DePace NL, Colombo J. Long-COVID syndrome and the cardiovascular system: a review of neurocardiologic effects on multiple systems. Curr Cardiol Rep. (2022) 24:1711&#x2013;26. doi: 10.1007/s11886-022-01786-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-022-01786-2</ArticleId><ArticleId IdType="pmc">PMC9524329</ArticleId><ArticleId IdType="pubmed">36178611</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. . The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. (2023) 55:101762. doi: 10.1016/j.eclinm.2022.101762, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV. Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr Clin Res Rev. (2021) 15:145&#x2013;6. doi: 10.1016/j.dsx.2020.12.025, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence . COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE; (2020). Available at: https://www.nice.org.uk/guidance/ng188 (Accessed Mar 30, 2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. (2022) 22:e102&#x2013;7. doi: 10.1016/S1473-3099(21)00703-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Henry BM, Favresse J, Plebani M. Addressing standardized definitions of post-COVID and long-COVID. Clin Chem Lab Med. (2023) 61:1361&#x2013;2. doi: 10.1515/cclm-2023-0390, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2023-0390</ArticleId><ArticleId IdType="pubmed">37098111</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandan JS, Brown KR, Simms-Williams N, Bashir NZ, Camaradou J, Heining D, et al. . Non-pharmacological therapies for post-viral syndromes, including long Covid: a systematic review. Int J Environ Res Public Health. (2023) 20:3477. doi: 10.3390/ijerph20043477, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20043477</ArticleId><ArticleId IdType="pmc">PMC9967466</ArticleId><ArticleId IdType="pubmed">36834176</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan A, Broughan J, McCombe G, Brennan J, Collins C, Fawsitt R, et al. . Enhancing the management of long COVID in general practice: a scoping review. BJGP Open. (2022) 6:BJGPO.2021.0178. doi: 10.3399/BJGPO.2021.0178</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGPO.2021.0178</ArticleId><ArticleId IdType="pmc">PMC9680752</ArticleId><ArticleId IdType="pubmed">35256357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Moschopoulos CD, Margalit I, Gkrania-Klotsas E, Landi F, Stahl JP, et al. . ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. (2022) 28:955&#x2013;72. doi: 10.1016/j.cmi.2022.02.018, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. . Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. (2020) 127:104370. doi: 10.1016/j.jcv.2020.104370, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104370</ArticleId><ArticleId IdType="pmc">PMC7194648</ArticleId><ArticleId IdType="pubmed">32344321</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Lim EY, Metaxaki M, Jackson S, Mactavous L, BioResource NIHR, et al. . Spontaneous, persistent, T cell&#x2013;dependent IFN-&#x3b3; release in patients who progress to long Covid. Sci Adv. (2024) 10:eadi9379. doi: 10.1126/sciadv.adi9379, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adi9379</ArticleId><ArticleId IdType="pmc">PMC10881041</ArticleId><ArticleId IdType="pubmed">38381822</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. (2020) 55:105954. doi: 10.1016/j.ijantimicag.2020.105954, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105954</ArticleId><ArticleId IdType="pmc">PMC7118634</ArticleId><ArticleId IdType="pubmed">32234467</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MAF, Neves PFMD, Lima SS, Lopes JDC, Torres MKDS, Vallinoto IMVC, et al. . Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol. (2022) 12:922422. doi: 10.3389/fcimb.2022.922422, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Lim EY, Mactavous L, Lyons PA, Doffinger R, Bradley JR, et al. . Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID. EBioMedicine. (2022) 81:104129. doi: 10.1016/j.ebiom.2022.104129, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104129</ArticleId><ArticleId IdType="pmc">PMC9235296</ArticleId><ArticleId IdType="pubmed">35772216</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn KL, Lam GY, Walsh JF, Bh&#xe9;reur A, Brown AD, Chow CW, et al. . Cardiovascular considerations in the management of people with suspected long Covid. Can J Cardiol. (2023) 39:741&#x2013;53. doi: 10.1016/j.cjca.2023.04.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2023.04.003</ArticleId><ArticleId IdType="pmc">PMC10160565</ArticleId><ArticleId IdType="pubmed">37030518</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R, Shunmugam L, Naidoo K. Long COVID: an approach to clinical assessment and management in primary care. South Afr Fam Pract. (2023) 65:e1&#x2013;e10. doi: 10.4102/safp.v65i1.5751</Citation><ArticleIdList><ArticleId IdType="doi">10.4102/safp.v65i1.5751</ArticleId><ArticleId IdType="pmc">PMC10331047</ArticleId><ArticleId IdType="pubmed">37427773</ArticleId></ArticleIdList></Reference><Reference><Citation>Leggat FJ, Heaton-Shrestha C, Fish J, Siriwardena AN, Domeney A, Rowe C, et al. . An exploration of the experiences and self-generated strategies used when navigating everyday life with long Covid. BMC Public Health. (2024) 24:789. doi: 10.1186/s12889-024-18267-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-024-18267-6</ArticleId><ArticleId IdType="pmc">PMC10938753</ArticleId><ArticleId IdType="pubmed">38481230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A, Lacombe V, Ravaiau C, Delattre E, Ghali M, Urbanski G, et al. . The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome. J Transl Med. (2023) 21:375. doi: 10.1186/s12967-023-04229-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04229-w</ArticleId><ArticleId IdType="pmc">PMC10248991</ArticleId><ArticleId IdType="pubmed">37291581</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kelly B, Vidal L, McHugh T, Woo J, Avramovic G, Lambert JS. Safety and efficacy of low dose naltrexone in a long Covid cohort; an interventional pre-post study. Brain Behav Immun Health. (2022) 24:100485. doi: 10.1016/j.bbih.2022.100485, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100485</ArticleId><ArticleId IdType="pmc">PMC9250701</ArticleId><ArticleId IdType="pubmed">35814187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross M, Lansang NM, Gopaul U, Ogawa EF, Heyn PC, Santos FH, et al. . What do I need to know about long-Covid-related fatigue, brain fog, and mental health changes? Arch Phys Med Rehabil. (2023) 104:996&#x2013;1002. doi: 10.1016/j.apmr.2022.11.021, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2022.11.021</ArticleId><ArticleId IdType="pmc">PMC10028338</ArticleId><ArticleId IdType="pubmed">36948378</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe0; M, Mercad&#xe9;-Besora N, Kolde R, Trinh NTH, Roel E, Burn E, et al. . The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med. (2024) 12:225&#x2013;36. doi: 10.1016/S2213-2600(23)00414-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00414-9</ArticleId><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha C, Baek G. Symptoms and management of long COVID: a scoping review. J Clin Nurs. (2024) 33:11&#x2013;28. doi: 10.1111/jocn.16150</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16150</ArticleId><ArticleId IdType="pubmed">34913540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang H-J, Lin C-W, Hsiao M-Y, Wang T-G, Liang H-W. Long COVID and rehabilitation. J Formos Med Assoc. (2024) 123:S61&#x2013;9. doi: 10.1016/j.jfma.2023.03.022, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10101546</ArticleId><ArticleId IdType="pubmed">37061399</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguarta-Val S, Varillas-Delgado D, Lizcano-&#xc1;lvarez &#xc1;, Molero-S&#xe1;nchez A, Melian-Ortiz A, Cano-de-la-Cuerda R, et al. . Effects of aerobic exercise therapy through Nordic walking program in lactate concentrations, fatigue and quality-of-life in patients with long-COVID syndrome: a non-randomized parallel controlled trial. J Clin Med. (2024) 13:1035. doi: 10.3390/jcm13041035, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13041035</ArticleId><ArticleId IdType="pmc">PMC10889227</ArticleId><ArticleId IdType="pubmed">38398348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewthwaite H, Byrne A, Brew B, Gibson PG. Treatable traits for long COVID. Respirology. (2023) 28:1005&#x2013;22. doi: 10.1111/resp.14596</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14596</ArticleId><ArticleId IdType="pubmed">37715729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Chen XK, Sit CHP, Liang X, Li MH, Ma ACH, et al. . Effect of physical exercise&#x2013;based rehabilitation on long Covid: a systematic review and meta-analysis. Med Sci Sports Exerc. (2024) 56:143&#x2013;54. doi: 10.1249/MSS.0000000000003280, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000003280</ArticleId><ArticleId IdType="pubmed">37586104</ArticleId></ArticleIdList></Reference><Reference><Citation>Grewal JS, Carlsten C, Johnston JC, Shah AS, Wong AW, Ryerson CJ. Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort. BMC Pulm Med. (2023) 23:84. doi: 10.1186/s12890-023-02376-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-023-02376-w</ArticleId><ArticleId IdType="pmc">PMC10008721</ArticleId><ArticleId IdType="pubmed">36907855</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallick D, Goyal L, Chourasia P, Zapata MR, Yashi K, Surani S. Covid-19 induced postural orthostatic tachycardia syndrome (POTS): a review. Cureus. (2023) 15:e36955. doi: 10.7759/cureus.36955</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36955</ArticleId><ArticleId IdType="pmc">PMC10065129</ArticleId><ArticleId IdType="pubmed">37009342</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinoza-Bravo C, Arnal-G&#xf3;mez A, Mart&#xed;nez-Arnau FM, N&#xfa;&#xf1;ez-Cort&#xe9;s R, Hern&#xe1;ndez-Guill&#xe9;n D, Flor-Rufino C, et al. . Effectiveness of functional or aerobic exercise combined with breathing techniques in telerehabilitation for patients with long Covid: a randomized controlled trial. Phys Ther. (2023) 103:pzad118. doi: 10.1093/ptj/pzad118</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzad118</ArticleId><ArticleId IdType="pubmed">37658773</ArticleId></ArticleIdList></Reference><Reference><Citation>Binetti J, Real M, Renzulli M, Bertran L, Riesco D, Perpi&#xf1;an C, et al. . Clinical and biomarker profile responses to rehabilitation treatment in patients with long COVID characterized by chronic fatigue. Viruses. (2023) 15:1452. doi: 10.3390/v15071452, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15071452</ArticleId><ArticleId IdType="pmc">PMC10384083</ArticleId><ArticleId IdType="pubmed">37515140</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollini E, Lazzarini SG, Cordani C, Del Furia MJ, Kiekens C, Negrini S, et al. . Effectiveness of rehabilitation interventions on adults with Covid-19 and post&#x2013;Covid-19 condition. A systematic review with meta-analysis. Arch Phys Med Rehabil. (2024) 105:138&#x2013;49. doi: 10.1016/j.apmr.2023.08.023, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2023.08.023</ArticleId><ArticleId IdType="pubmed">37802177</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Pozas O, Mel&#xe9;ndez-Oliva E, Rolando LM, Rico JAQ, Corbellini C, S&#xe1;nchez Romero EA. The pulmonary rehabilitation effect on long Covid-19 syndrome: a systematic review and meta-analysis. Physiother Res Int. (2024) 29:e2077. doi: 10.1002/pri.2077, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pri.2077</ArticleId><ArticleId IdType="pubmed">38389299</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V, Stefanou M-I, Demetriou M, Siafakas N, Makris M, Tsivgoulis G, et al. . Long COVID and neuropsychiatric manifestations (review). Exp Ther Med. (2022) 23:363. doi: 10.3892/etm.2022.11290, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraeinejad A. Brain fog as a long-term sequela of COVID-19. SN Compr Clin Med. (2022) 5:9. doi: 10.1007/s42399-022-01352-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01352-5</ArticleId><ArticleId IdType="pmc">PMC9685075</ArticleId><ArticleId IdType="pubmed">36466122</ArticleId></ArticleIdList></Reference><Reference><Citation>Sowerby LJ, Almubarak Z, Biadsee A, Rocha T, Hopkins C. Coronavirus disease 2019 related parosmia: an exploratory survey of demographics and treatment strategies. J Laryngol Otol. (2023) 137:1256&#x2013;60. doi: 10.1017/S0022215123000713, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215123000713</ArticleId><ArticleId IdType="pmc">PMC10627779</ArticleId><ArticleId IdType="pubmed">37194063</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint LL, Bratty AJ. Amygdala and insula retraining (AIR) significantly reduces fatigue and increases energy in people with long COVID. Zahiruddin S, editor. Evid Based Complement Alternat Med. (2023) 2023:1&#x2013;8. doi: 10.1155/2023/7068326, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/7068326</ArticleId><ArticleId IdType="pmc">PMC10365910</ArticleId><ArticleId IdType="pubmed">37492483</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson L, Maina A, Compratt T, Harden S, Aaroe A, Copas W, et al. . Stellate ganglion block relieves long COVID-19 symptoms in 86% of patients: a retrospective cohort study. Cureus. (2023) 15:e45161. doi: 10.7759/cureus.45161</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.45161</ArticleId><ArticleId IdType="pmc">PMC10498998</ArticleId><ArticleId IdType="pubmed">37711269</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu LD, Duricka DL. Stellate ganglion block reduces symptoms of long COVID: a case series. J Neuroimmunol. (2022) 362:577784. doi: 10.1016/j.jneuroim.2021.577784, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577784</ArticleId><ArticleId IdType="pmc">PMC8653406</ArticleId><ArticleId IdType="pubmed">34922127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick K, Khan MH, Deng Y, Shah KB. A review of stellate ganglion block as an adjunctive treatment modality. Cureus. (2023) 15:e35174. doi: 10.7759/cureus.35174</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.35174</ArticleId><ArticleId IdType="pmc">PMC10029323</ArticleId><ArticleId IdType="pubmed">36949968</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel V, Patwardhan AM, Ibrahim M, Howe CL, Schultz DM, Shankar H. Complications associated with stellate ganglion nerve block: a systematic review. Reg Anesth Pain Med. (2019) 44:669&#x2013;78. doi: 10.1136/rapm-2018-100127, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2018-100127</ArticleId><ArticleId IdType="pmc">PMC9034660</ArticleId><ArticleId IdType="pubmed">30992414</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieniak M, Oleszkiewicz A, Avaro V, Calegari F, Hummel T. Olfactory training &#x2013; thirteen years of research reviewed. Neurosci Biobehav Rev. (2022) 141:104853. doi: 10.1016/j.neubiorev.2022.104853, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2022.104853</ArticleId><ArticleId IdType="pubmed">36064146</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Rissom K, Reden J, H&#xe4;hner A, Weidenbecher M, H&#xfc;ttenbrink K. Effects of olfactory training in patients with olfactory loss. Laryngoscope. (2009) 119:496&#x2013;9. doi: 10.1002/lary.20101</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.20101</ArticleId><ArticleId IdType="pubmed">19235739</ArticleId></ArticleIdList></Reference><Reference><Citation>Isman A, Nyquist A, Strecker B, Harinath G, Lee V, Zhang X, et al. . Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19. Brain Behav Immun Health. (2024) 36:100733. doi: 10.1016/j.bbih.2024.100733, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2024.100733</ArticleId><ArticleId IdType="pmc">PMC10862402</ArticleId><ArticleId IdType="pubmed">38352659</ArticleId></ArticleIdList></Reference><Reference><Citation>Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. (2014) 33:451&#x2013;9. doi: 10.1007/s10067-014-2517-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-014-2517-2</ArticleId><ArticleId IdType="pmc">PMC3962576</ArticleId><ArticleId IdType="pubmed">24526250</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Tian L, Marconi VC, Shafer R, McComsey GA, Miglis M, et al. . Low-dose naltrexone use for the management of post-acute sequelae of COVID-19. Int Immunopharmacol. (2023) 124:110966. doi: 10.1016/j.intimp.2023.110966, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2023.110966</ArticleId><ArticleId IdType="pmc">PMC11028858</ArticleId><ArticleId IdType="pubmed">37804660</ArticleId></ArticleIdList></Reference><Reference><Citation>Partridge S, Quadt L, Bolton M, Eccles J, Thompson C, Colasanti A, et al. . A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia. Heliyon. (2023) 9:e15638. doi: 10.1016/j.heliyon.2023.e15638, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e15638</ArticleId><ArticleId IdType="pmc">PMC10189400</ArticleId><ArticleId IdType="pubmed">37206027</ArticleId></ArticleIdList></Reference><Reference><Citation>De Domenico M. Prevalence of long COVID decreases for increasing COVID-19 vaccine uptake. Mutheneni SR, editor. PLOS Glob Public Health. (2023);3:e0001917. doi: 10.1371/journal.pgph.0001917</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0001917</ArticleId><ArticleId IdType="pmc">PMC10284420</ArticleId><ArticleId IdType="pubmed">37342998</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine. (2023) 41:1783&#x2013;90. doi: 10.1016/j.vaccine.2023.02.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Seb&#x151;k S, Gyires K. Long COVID and possible preventive options. Inflammopharmacology. (2023) 31:2807&#x2013;17. doi: 10.1007/s10787-023-01204-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01204-1</ArticleId><ArticleId IdType="pmc">PMC10692252</ArticleId><ArticleId IdType="pubmed">37344737</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannous J, Pan AP, Potter T, Bako AT, Dlouhy K, Drews A, et al. . Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population. BMJ Open. (2023) 13:e067611. doi: 10.1136/bmjopen-2022-067611, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-067611</ArticleId><ArticleId IdType="pmc">PMC10083521</ArticleId><ArticleId IdType="pubmed">37019490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam ICH, Zhang R, Man KKC, Wong CKH, Chui CSL, Lai FTT, et al. . Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection. Nat Commun. (2024) 15:1716. doi: 10.1038/s41467-024-45953-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-45953-1</ArticleId><ArticleId IdType="pmc">PMC10894867</ArticleId><ArticleId IdType="pubmed">38403654</ArticleId></ArticleIdList></Reference><Reference><Citation>Razzaghi H, Forrest CB, Hirabayashi K, Wu Q, Allen AJ, Rao S, et al. . Vaccine effectiveness against long COVID in children. Pediatrics. (2024) 153:e2023064446. doi: 10.1542/peds.2023-064446, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-064446</ArticleId><ArticleId IdType="pmc">PMC10979300</ArticleId><ArticleId IdType="pubmed">38225804</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. (2022) 103:154&#x2013;62. doi: 10.1016/j.bbi.2022.04.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. . Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. (2022) 377:e069676. doi: 10.1136/bmj-2021-069676, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. . Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. eClinicalMedicine. (2022) 53:101624. doi: 10.1016/j.eclinm.2022.101624, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Metaxaki M, Wills MR, Sithole N. Reduced incidence of long coronavirus disease referrals to the Cambridge university teaching hospital long coronavirus disease clinic. Clin Infect Dis. (2023) 76:738&#x2013;40. doi: 10.1093/cid/ciac630, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac630</ArticleId><ArticleId IdType="pmc">PMC9384550</ArticleId><ArticleId IdType="pubmed">35913432</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Abu Jabal K, et al. . Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020&#x2013;21, Israel. NPJ Vaccines. (2022) 7:101. doi: 10.1038/s41541-022-00526-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00526-5</ArticleId><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med. (2023) 10:1187163. doi: 10.3389/fmed.2023.1187163</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo JC, Battistini F, Cordobilla B, Zaragoz&#xe1; MC, Sanmartin-Senta&#xf1;es R, Alegre-Martin J, et al. . Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study. J Transl Med. (2024) 22:343. doi: 10.1186/s12967-024-05148-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-024-05148-0</ArticleId><ArticleId IdType="pmc">PMC11005215</ArticleId><ArticleId IdType="pubmed">38600563</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>